Pharmacological Profile of AZD8871 (LAS191351), a Novel Inhaled Dual M3 Receptor Antagonist/β2-Adrenoceptor Agonist Molecule with Long-Lasting Effects and Favorable Safety Profile-Reference-Cited by-同舟云学术

Pharmacological Profile of AZD8871 (LAS191351), a Novel Inhaled Dual M3 Receptor Antagonist/β2-Adrenoceptor Agonist Molecule with Long-Lasting Effects and Favorable Safety Profile

Published:2019-05-13 Issue:1 Volume:370 Page:127-136
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Aparici Mònica^ORCID,Carcasona Carla,Ramos Israel,Montero José Luís,Otal Raquel,Ortiz José Luís,Cortijo Julio,Puig Carlos,Vilella Dolors,De Alba Jorge,Doe Chris,Gavaldà Amadeu,Miralpeix Montserrat

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference51 articles.

1. Pharmacological preclinical characterization of LAS190792, a novel inhaled bifunctional muscarinic receptor antagonist/β2-adrenoceptor agonist (MABA) molecule;Aparici;Pulm Pharmacol Ther,2017

2. In vitro and in vivo preclinical profile of abediterol (LAS100977), an inhaled long-acting β2-adrenoceptor agonist, compared with indacaterol, olodaterol and vilanterol;Aparici;Eur J Pharmacol,2016

3. Pharmacological Characterization of Abediterol, a Novel Inhaled β2-Adrenoceptor Agonist with Long Duration of Action and a Favorable Safety Profile in Preclinical Models

4. Distribution of Receptor Targets in the Lung

5. Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New promising agents against COPD and asthma among the amides of 1-oxo-3-phenyl-isochroman-6-carboxylic acid;Biophysical Bulletin;2023-12-30

2. Advances in adrenergic receptors for the treatment of chronic obstructive pulmonary disease: 2023 update;Expert Opinion on Pharmacotherapy;2023-11-15

3. Navafenterol for chronic obstructive pulmonary disease therapy;Expert Opinion on Investigational Drugs;2023-04-03

4. 2-Phenethylamines in Medicinal Chemistry: A Review;Molecules;2023-01-14

5. The Bronchoprotective Effects of Dual Pharmacology, Muscarinic Receptor Antagonist and β2 Adrenergic Receptor Agonist Navafenterol in Human Small Airways;Cells;2023-01-06